Difference between revisions of "Category:Non-small cell lung cancer regimens"
Jump to navigation
Jump to search
(Created page with "Regimens used specifically in the treatment of non-small cell lung cancer. Category:Thoracic oncology regimens") |
m |
||
| Line 1: | Line 1: | ||
Regimens used specifically in the treatment of [[non-small cell lung cancer]]. | Regimens used specifically in the treatment of [[non-small cell lung cancer]]. | ||
| − | [[Category: | + | [[Category:Lung cancer regimens]] |
Latest revision as of 14:50, 29 July 2017
Regimens used specifically in the treatment of non-small cell lung cancer.
Pages in category "Non-small cell lung cancer regimens"
The following 14 pages are in this category, out of 14 total.
N
- Non-small cell lung cancer
- Non-small cell lung cancer - historical
- Non-small cell lung cancer - null regimens
- Non-small cell lung cancer, ALK-positive
- Non-small cell lung cancer, BRAF-mutated
- Non-small cell lung cancer, CNS metastases
- Non-small cell lung cancer, EGFR-mutated
- Non-small cell lung cancer, HER2-mutated
- Non-small cell lung cancer, KRAS-mutated
- Non-small cell lung cancer, MET-mutated
- Non-small cell lung cancer, nonsquamous
- Non-small cell lung cancer, RET-positive
- Non-small cell lung cancer, ROS1-positive
- Non-small cell lung cancer, squamous